Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S2W-32494 · Session 2

Whether it will review and evaluate the impact of Prevenar on pneumococcal immunisation and, if so, when it will do so.

Answered Asked by Euan Robson LD Lodged 16 Mar 2007

The question

To ask the Scottish Executive whether it will review and evaluate the impact of Prevenar on pneumococcal immunisation and, if so, when it will do so.

The answer

Answered by Andy Kerr on 27 Mar 2007 · 11 days after it was lodged, on time

Health Protection Scotland is monitoring the incidence of invasivepneumococcal disease in children and adults to detect any reductions in its occurrence.It will then evaluate the impact of the introduction of Prevenar into the routinechildhood immunisation schedule and the current catch-up campaign.

In the Official Report

No contribution in the Official Report cites S2W-32494 by reference.